Syneron Medical Ltd

Type: Company
Name: Syneron Medical Ltd
First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Form 6-K Syneron Medical Ltd. For: Jun 17

StreetInsider.com - Form 6-K Syneron Medical Ltd. For: Jun 17 ... [Published Street Insider - Jun 17 2013]
First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports
Lane Crawford
Lane Crawford

TANDA Skincare & Teeth Whitening Machines and meHair Removal Machines are Now Available at JOYCE BEAUTY, PR Newswire

/PRNewswire/ -- Home use beauty machines are well-received by both male and female nowadays. Tanda skincare & teeth whitening machines and me hair removal machines from Syneron Beauty Inc. are now available at JOYCE BEAUTY HONG KONG.The Tanda brand and ... [Published Yahoo! Finance - Jun 17 2013]
First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Syneron Medical Shares Sinking Lower, Down 2.5%

(Financial News Network On) Syneron Medical (NASDAQ:ELOS) is one of today's biggest movers, down 2.5% to $8.58. The Dow is down 0.4% to 15,111 and the S&P is currently down 0.3% to 1,632. Syneron Medical Ltd. designs, develops, and markets aesthetic ... [Published Individual.com - Jun 14 2013]
First reported Jun 06 2013 - Updated Jun 06 2013 - 1 reports

Is Syneron Medical Ltd. (ELOS) Going to Burn These Hedge Funds?

Is Syneron Medical Ltd. (NASDAQ:ELOS) undervalued? Money managers are betting on the stock. The number of long hedge fund bets moved up by 1 in recent months. According to most stock holders, hedge funds are seen as slow, outdated financial tools of ... [Published InsiderMonkey.com - Jun 06 2013]
First reported May 31 2013 - Updated May 31 2013 - 1 reports

Syneron Medical Q1 net loss decreases

Syneron Medical Ltd., an aesthetic device company, has reported that net loss attributable to shareholders for the first quarter ended March 31, 2013 was $2.44 million, or $0.07 loss per share, compared to a net loss attributable to shareholders of $2.61 ... [Published Individual.com - May 31 2013]
First reported May 23 2013 - Updated May 23 2013 - 1 reports
Standard & Poor's
Standard & Poor's

Syneron Medical Makes a Move: Down 4.2%

(Financial News Network On) One of today's stocks on the move is Syneron Medical (NASDAQ:ELOS), down 4.2% to $8.73. The S&P is trading lower by 0.3% to 1,650 and the Dow is trading fractionally lower to 15,304. There is potential upside of 94.7% for ... [Published Individual.com - May 23 2013]
First reported May 23 2013 - Updated May 23 2013 - 1 reports
Syneron Medical Ltd
Syneron Medical Ltd

Form 6-K Syneron Medical Ltd. For: May 23

StreetInsider.com - Form 6-K Syneron Medical Ltd. For: May 23 ... [Published Street Insider - May 23 2013]
First reported May 22 2013 - Updated May 22 2013 - 3 reports

Syneron Medical's CEO Discusses Q1 2013 Results - Earnings Call Transcript

Syneron Medical Ltd. (ELOS) Q1 2013 Earnings Conference Call May 22, 2013 8:30 AM ETOperatorGood day ladies and gentleman and welcome to the Syneron Medical First Quarter 2013 Results Conference Call. At this time, all participants are in a listen-only ... [Published Seeking Alpha - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Syneron Medical (ELOS) Announces Quarterly Earnings, Meets Expectations

Syneron Medical (NASDAQ: ELOS) issued its quarterly earnings data on Wednesday. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.02, reports. The company had revenue of $61.20 million for the quarter, ... [Published American Banking News - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Syneron Medical Earnings: Everything You Must Know Now

Syneron Medical Ltd. ( NASDAQ:ELOS ) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.Markets are at 5-year highs! Discover ... [Published Wall St. Cheat Sheet - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Syneron Medical (ELOS): Q1 EPS of $0.02 in-line. Revenue of $61.2M beats by $0.01M. (PR)

:52 AM ET Syneron Medical (ELOS): Q1 EPS of $0.02 in-line. Revenue of $61.2M beats by $0.01M. (PR) ... [Published Seeking Alpha - May 22 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Syneron Medical Earnings: Your Sneak Peek to the Big Announcement

Syneron Medical ( NASDAQ:ELOS ) will report earnings before markets open on Wednesday, May 22nd. Syneron Medical Ltd. designs, develops, and markets aesthetic medical products based on proprietary Electro-Optical Synergy, or ELOS technologies. The ... [Published Wall St. Cheat Sheet - May 21 2013]

Quotes

...Some currently marketed products against which Insys directly competes include Teva Pharmaceutical Industries Ltd. "s (TEVA) Fentora and Actiq, Orexo AB's Abstral, Archimedes Pharma Ltd." s Lazanda and BioDelivery Sciences International Inc.'s (BDSI) Onsolis...
3 Healthcare Companies With Recent Intensive Insider Buying [Published Seeking Alpha - Jun 09 2013]
Hugo Goldman, CFO of Syneron, said, "During the first quarter, our cash position decreased $11.8 million. This was driven by increased product inventory to support the launch of the me home-use hair removal system and the Pearl Brilliant White System in the US, our investments in the EBU segment, and the timing of certain accounts receivable and payable. We continue to have a strong balance sheet with no debt. We are committed to improving revenue growth and profitability by focusing on growth opportunities, enhancing sales and operating efficiency, including shifting resources and tightening costs."
Syneron Medical Q1 net loss decreases [Published Individual.com - May 31 2013]
Shimon Eckhouse, Chief Executive Officer of Syneron, said, "In the PAD segment, revenue was down 5 percent, while in the EBU segment we achieved another quarter of record revenue. Although the basic demand for our products and technologies on a global basis remains strong, we have some areas in which we are implementing new strategies to drive growth and profitability. On the revenue side, we saw moderate PAD segment growth in all geographies except for EMEA and Japan, which were impacted by macroeconomic conditions. There continues to be strong interest in our recently launched products, including at several major industry conferences during the quarter. We remain on track with our UltraShape U S clinical trial and recently introduced several enhancements to our body shaping product portfolio. We have begun making strategic additions to our U S sales team to target the gradually recovering economy, including the non-core market, along with selective resource reallocations within our global team to focus on high demand geographies. This will support operating margin expansion as we grow revenue and further optimize our operating infrastructure."
Syneron Medical Reports 1Q 2013 Results [Published Individual.com - May 28 2013]

More Content

All (57) | News (20) | Reports (5) | Blogs (11) | Audio/Video (0) | Fact Sheets (1) | Press Releases (20)
sort by: Date | Relevance
Form 6-K Syneron Medical Ltd. For: Jun 17 [Published Street Insider - Jun 17 2013]
TANDA Skincare & Teeth Whitening Machines and m... [Published Yahoo! Finance - Jun 17 2013]
Syneron Medical Shares Sinking Lower, Down 2.5% [Published Individual.com - Jun 14 2013]
Global Ablation Technologies Market Report 2012... [Published Individual.com - Jun 11 2013]
3 Healthcare Companies With Recent Intensive In... [Published Seeking Alpha - Jun 09 2013]
Accuray Incorporated (ARAY): Insiders Are Buyin... [Published InsiderMonkey.com - Jun 06 2013]
Is Syneron Medical Ltd. (ELOS) Going to Burn Th... [Published InsiderMonkey.com - Jun 06 2013]
This Metric Says You Are Smart to Sell Natus Me... [Published InsiderMonkey.com - Jun 03 2013]
Syneron Medical Q1 net loss decreases [Published Individual.com - May 31 2013]
Syneron to Present at the Jefferies 2013 Global... [Published Barchart - May 30 2013]
Syneron to Present at the Jefferies 2013 Global... [Published PR Newswire: Health - May 30 2013]
2 Potentially Explosive Small Cap Stocks For 2013 [Published Seeking Alpha - May 30 2013]
Syneron Medical Reports 1Q 2013 Results [Published Individual.com - May 28 2013]
Syneron Medical Makes a Move: Down 4.2% [Published Individual.com - May 23 2013]
Free Research Reports on CLNT, ELOS, LOW and RC... [Published I Stock Analyst - May 23 2013]
Form 6-K Syneron Medical Ltd. For: May 23 [Published Street Insider - May 23 2013]
Syneron Medical's CEO Discusses Q1 2013 Results... [Published Seeking Alpha - May 22 2013]
Syneron posts smaller 1Q loss despite lower sales [Published CNBC - May 22 2013]
Syneron Medical (ELOS) Announces Quarterly Earn... [Published American Banking News - May 22 2013]
Syneron Medical Earnings: Everything You Must K... [Published Wall St. Cheat Sheet - May 22 2013]
Syneron Medical Earnings: Everything You Must K... [Published Wall St. Cheat Sheet - May 22 2013]
Syneron Medical (ELOS): Q1 EPS of $0.02 in-line... [Published Seeking Alpha - May 22 2013]
Syneron Reports First Quarter 2013 Results [Published Reuters - May 22 2013]
SYNERON MEDICAL LTD. : Syneron Reports First Qu... [Published 4 Traders - May 22 2013]
Syneron Reports First Quarter 2013 Results [Published Financial Services - May 22 2013]
Continue to the full story [Published Nasdaq - May 21 2013]
Syneron Medical Earnings: Your Sneak Peek to th... [Published Wall St. Cheat Sheet - May 21 2013]
Syneron presenta i miglioramenti ai suoi innova... [Published PR Newswire: Policy & Public Interest - May 16 2013]
Syneron presenta mejoras dentro de sus innovado... [Published PR Newswire: Policy & Public Interest - May 16 2013]
Syneron présente ses innovations pour le remode... [Published PR Newswire: Policy & Public Interest - May 16 2013]
1 2
In Focus
  •  
Neil Chriss, Seth Klarman, Jennifer Chen, [more]
  •  
Leerink Swann & Co Inc, Tefron Ltd, QVC, [more]
  •  
European Broadcasting Union, US Securities and Exchange Commission, FDA Food & Drug Administration, [more]
  •  
Stocks, Healthcare Conference, Earnings Per Share, [more]
  •  
Xignite Financials, S&P 500, danazol, [more]
  •  
New York City, Sunnyvale (California, United States), San Francisco (United States), [more]
  •  
Israel, United States, Japan, [more]
  •  
Diseases, Medication, Research & Development, [more]
  •  
Telecom, Banking & Financial Services, Health
Wall St. Cheat Sheet, PR Newswire: Health, MarketIntelligenceCenter.com, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Syneron Medical Earnings: Everything You Must K... [Published Wall St. Cheat Sheet - May 22 2013]
Syneron Medical Ltd. ( NASDAQ:ELOS ) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.Markets are at 5-year highs! Discover ...
Syneron Medical Earnings: Everything You Must K... [Published Wall St. Cheat Sheet - May 22 2013]
Syneron Medical Ltd. ( NASDAQ:ELOS ) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Markets are at 5-year highs! Discover ...
Syneron Medical Earnings: Your Sneak Peek to th... [Published Wall St. Cheat Sheet - May 21 2013]
Syneron Medical ( NASDAQ:ELOS ) will report earnings before markets open on Wednesday, May 22nd. Syneron Medical Ltd. designs, develops, and markets aesthetic medical products based on proprietary Electro-Optical Synergy, or ELOS technologies. The ...
Analysts: Facebook May Get Hurt and 3 Other Ana... [Published Wall St. Cheat Sheet - Apr 16 2013]
Facebook ( NASDAQ:FB ): Facebook shares may be hurt by slowing monetization, according to Pacific Crest, which also warns the social network may report results in the first half of the year that are below estimates. The firm keeps a Sector Perform ...
Syneron Medical (ELOS) Showing Bullish Technica... [Published MarketIntelligenceCenter.com - Mar 27 2013]
Syneron Medical (NASDAQ: ELOS) closed Tuesday's trading session at $10.11. In the past year, the stock has hit a 52-week low of $7.21 and 52-week high of $11.24. Syneron Medical (ELOS) stock has been showing support around $9.67 and resistance in the ...
1 2 3

Press Releases

sort by: Date | Relevance
Syneron to Present at the Jefferies 2013 Global... [Published PR Newswire: Health - May 30 2013]
Syneron Reports First Quarter 2013 Results [Published Financial Services - May 22 2013]
Syneron presenta i miglioramenti ai suoi innova... [Published PR Newswire: Policy & Public Interest - May 16 2013]
Syneron presenta mejoras dentro de sus innovado... [Published PR Newswire: Policy & Public Interest - May 16 2013]
Syneron présente ses innovations pour le remode... [Published PR Newswire: Policy & Public Interest - May 16 2013]
1 2 3 4
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.